Improving Outcomes of Chemotherapy: Established and Novel Options for Myeloprotection in the COVID-19 Era

Overview of attention for article published in Frontiers in oncology, July 2021

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age and source (63rd percentile)

Mentioned by

twitter: 4 X users

Citations

dimensions_citation: 14 Dimensions

Readers on

mendeley: 43 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 15,696 followers.

Improving Outcomes of Chemotherapy: Established and Novel Options for Myeloprotection in the COVID-19 Era https://t.co/sqymCbeU6Q

12 Dec 2021

Reply Repost Favourite

Improving Outcomes of Chemotherapy: Established and Novel Options for Myeloprotection in the COVID-19 Era by Gary H Lyman https://t.co/wDy6UoH0V4

26 Jul 2021

Reply Repost Favourite

New research: Improving Outcomes of Chemotherapy: Established and Novel Options for Myeloprotection in the COVID-19 Era: Chemotherapy-induced damage of hematopoietic stem and progenitor cells (HPSCs) often results in myelosuppression that… https://t.co/WRt

09 Jul 2021

Reply Repost Favourite

Improving Outcomes of Chemotherapy: Established and Novel Options for Myeloprotection in the COVID-19 Era https://t.co/KNqwIDtQFA Novel agents in clinical development for prevention of myelosuppression in pts receiving cancer chemotherapy @NicoleKuderer

08 Jul 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.